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Madam, Adult haemoglobin (Hb) comprises of 2 alpha and
2 beta-globin chains, each having a haem molecule
attached. In healthy individuals, around 95-98% HbA
(α2β2) and 2–3.5% of Hb A2 (α2δ2) are present. The genetic
defect of globin chain in which valine is replaced for
glutamic acid at position 6 of β globin chain results in sickle
haemoglobin (HbS). Homozygous genetic defect (βSβS)
results in a symptomatic disease called 'sickle cell anaemia'
whereas, heterozygous (ββS) state is asymptomatic and
commonly called as "sickle cell trait'.1 On deoxygenation
and dehydration, HbS undergoes irreversible
polymerization causing deleterious effects in vivo.2 Around
3.2 million people have sickle-cell disease worldwide, with
about 80% cases in Africa. About 0.5 to 1 per cent of the
Pakistani population carries HbS.3 Currently, high-
performance liquid chromatography (HPLC) is the
preferred method in which HbS elutes at retention time
ranging in between 4.1 to 4.7 minutes. Several other variant
haemoglobins cause interference by co-eluting at same
retention time include HbA2, Hb Q-Thailand, Hb Manitoba,
Hb Russ, Hb Stanlivelly-II, HbE- Saskatoon, Hb Montgomery
and many more.4 Therefore, it is difficult to identify and
differentiate HbS precisely from interfering variant
haemoglobins for proper diagnosis and future genetic
counselling of patients. The definitive test for this purpose
is molecular detection of underlying mutation either by
polymerase chain reaction (PCR) or sequencing of the beta-
globin gene. Molecular tests, however, are expensive and
require expertise. Therefore, these tests are not widely
available in Pakistan and other resource constraint
countries. World's leading quality assurance organizations
such as College of American Pathologists (CAP)
recommend that all cases found HbS positive in the
primary screening should be confirmed by secondary
testing5 this can easily be achieved by sickling test. In the
sickling test, the sample is combined with reducing agent
(Sodium Met bisulfate) resulting in red cell hypoxia. Cells
with HbS change to sickle shape from their normal
biconcave shape, diagnosed by microscopic examination
along with controls. This cost-effective and readily available
technique helps to differentiate HbS from other variants.
Therefore, every laboratory should confirm the presence of
HbS by sickling test, and the government should ensure
the availability of molecular tests at the mass level at a
reduced cost supported by the efficient health insurance
system. The impact of these strategies will provide accurate
and timely diagnosis, and hence appropriate management
and future genetic counselling of the patients could be
easily achieved.
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